Delivery Order SPE2DB22D2007-SPE2DB25FH8ES

Award Date 1/13/25
Potential Completion Date 2/4/25
Potential Value $11K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $10,345.32, is for the delivery of PADCEV 30 MG vials. This is a delivery order contract with a firm fixed price pricing type, and the ultimate completion date is December 30, 2024. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a...
This is a delivery order contract awarded to Amerisourcebergen Drug Corp by the Defense Logistics Agency (DLA) for the supply of PADCEV 30 MG VIALS. The contract has a ceiling value of $8,315.70 and a period of performance through January 30, 2025. The contract is a firm fixed-price arrangement with no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of PADCEV 30 MG vials. The contract is a firm fixed-price delivery order with a ceiling value of $39,998.88 and is set to be completed by September 5, 2024. Amerisourcebergen is providing these critical pharmaceutical products to support military treatment facilities and other federal healthcare providers. This delivery order is part...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of PADCEV 30 MG vials. The contract has a ceiling value of $7,499.79 and runs through November 4, 2024. The contract is a firm-fixed-price delivery order, with no set-aside designation. As a key supplier of pharmaceutical and medical products to the federal government, including military treatment facilities and veterans' healthcare...
This federal contract award, valued at $18,479.50, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of PADCEV 20 MG VIALS, a pharmaceutical product, with a completion date of March 25, 2025. The contract is a Firm Fixed Price Delivery Order and was not set aside for any specific business type. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC)...
This firm-fixed-price delivery order was awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp's Corporate Office Division for the provision of 4564441020 PADCEV 30 MG VIALS. The contract has an ultimate completion date of May 20, 2024 and a ceiling value of $9,999.72. AmerisourceBergen, a major pharmaceutical distribution company, holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at up to $999,999,999.00 through December...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The $14,999.58 firm-fixed price contract is for the delivery of PADCEV 30 MG Vials, a pharmaceutical product. The contract is not designated as a set-aside and is part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 that Amerisourcebergen holds with the DLA Troop Support Medical. This single-award IDC serves...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) for the delivery of PADCEV 30 MG VIALS. The contract is a Firm Fixed Price Delivery Order with a ceiling value of $5,543.80 and a period of performance through March 27, 2025. The contract does not have a set-aside designation, indicating open competition. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award, valued at $2,771.90, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order for PADCEV 30 MG VIALS, with a firm fixed price and an ultimate completion date of March 25, 2025. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp (ABDC) Corporate Office Division. The contract is for the supply of PADCEV 30 MG vials, a pharmaceutical product. The contract has a total ceiling value of $24,999.30 and is a Firm Fixed Price type. There is no set-aside designation for this award. Amerisourcebergen is a major supplier of pharmaceutical products and medical supplies to the U.S. federal...
  • SPE2DB22D2007
    Indefinite Delivery Contract
  • SPE2DB22D2007-SPE2DB25FH8ES
    Delivery Order

This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $11,087.60, is for the supply of PADCEV 30 MG VIALS medical products. It is a firm fixed-price contract with a completion date of February 4, 2025. The contract is not designated as a set-aside. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. Additionally, the company maintains a separate $750,000 IDC with the Department of Justice Federal Bureau of Investigation for similar medical products and prescription drugs.

Generated 5/21/25, 10:27 AM